Home › Funds › Tyro Capital Management LLC › NGNE
Tyro Capital Management LLC position in NGNE
NEUROGENE INC · Health Care
Tyro Capital Management LLC reported holding 304,401 shares of NGNE (NEUROGENE INC) in its Q3 2026 13F filing — a position valued at US$8.5M, representing 1.50% of its reported portfolio and ranking #20 among its reported holdings. Tyro Capital Management LLC first reported this position in Q3 2026.
Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR
How Tyro Capital Management LLC's NGNE position evolved
Tyro Capital Management LLC first disclosed a stake in NGNE in Q3 2026 at 304,401 shares (US$8.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 304.40K | $8.47M | New |
About NGNE and 13F data
NGNE (NEUROGENE INC) is a Health Care company. 38 other funds we track also report a position in NGNE — the largest reported positions include Samsara BioCapital, LLC (US$54.0M), Casdin Capital (US$48.6M), Redmile Group, LLC (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NGNE
- Samsara BioCapital, LLC 1.72M sh · $54.00M · Q2 2026
- Casdin Capital 1.55M sh · $48.60M · Q2 2026
- Redmile Group, LLC 1.41M sh · $44.41M · Q2 2026
- RTW INVESTMENTS, LP 1.36M sh · $42.85M · Q2 2026
- EcoR1 Capital, LLC 1.27M sh · $39.98M · Q2 2026
- BAKER BROS. ADVISORS LP 991.69K sh · $31.19M · Q2 2026
- Trails Edge Capital Partners, LP 714.88K sh · $22.48M · Q2 2026
- GREAT POINT PARTNERS LLC 352.18K sh · $11.08M · Q2 2026
- DAFNA Capital Management LLC 89.03K sh · $2.80M · Q2 2026
More on Tyro Capital Management LLC
FAQ
How long has Tyro Capital Management LLC held NGNE?
Tyro Capital Management LLC has disclosed NGNE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Tyro Capital Management LLC's current position in NGNE?
As of Q3 2026, Tyro Capital Management LLC holds 304.40K shares of NGNE (NEUROGENE INC), valued at $8.47M, representing 1.50% of its reported portfolio and ranking #20.
Has Tyro Capital Management LLC been buying or selling NGNE?
In the latest 13F filing (Q3 2026), Tyro Capital Management LLC newly opened its position in NGNE.
Which other funds hold NGNE?
Other major institutional holders of NGNE include Samsara BioCapital, LLC, Casdin Capital, Redmile Group, LLC, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.